Delivery Order SPE2DB20D3103-SPE2DB24FN6F4
Award Date 4/30/24
Potential Completion Date 5/1/24
Potential Value $32K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $12,568.40, is for the delivery of STELARA 90 MG/ML SYRINGE/ML medication and is a Firm Fixed Price Delivery Order. The contract has an ultimate completion date of December 5, 2023 and was awarded on December 4, 2023. This contract does not have a set-aside designation, indicating it was awarded through full and open competition....
- This federal contract award, valued at $20,944.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. The award has an ultimate completion date of April 24, 2023 and is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $14,248.83, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, with a completion date of November 8, 2023. The contract is a Delivery Order under a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award, valued at $15,422.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of STELARA 90 MG/ML SYRINGE, a specialty pharmaceutical product, with a completion date of January 17, 2024. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which is valued at up to $999,999,999...
- This federal contract award, valued at $82,480.90, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, with a completion date of November 23, 2021. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award, valued at $8,295.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product, to DLA facilities supporting the Department of Defense's (DoD) healthcare programs. The contract is a Delivery Order placed under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at...
- This federal contract award, valued at $48,403.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Stelara 90 mg/ml syringes, a specialty medication. This is a firm fixed-price delivery order contract with a period of performance ending on January 31, 2024. The contract was awarded on an unrestricted, full and open competition basis with no set-aside designation. Amerisourcebergen Drug Corp is a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $8,982.87 for the supply of STELARA 90 MG/ML SYRINGEML. The award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a civilian agency within the Department of Defense. The contract has an ultimate completion date of December 6, 2023 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition....
- This federal contract award, valued at $10,443.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4558771166 - STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 17, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999...
- This federal contract award, valued at $15,284.68, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product, with a completion date of December 5, 2023. The contract is an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to provide a...